PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+2.15%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$843M
AUM Growth
+$843M
(+12%)
Cap. Flow
+$124M
Cap. Flow
% of AUM
14.72%
Top 10 Holdings %
Top 10 Hldgs %
33.86%
Holding
109
New
20
Increased
44
Reduced
26
Closed
18
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$22.7M |
| 2 |
CVS Health
CVS
|
$21.5M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$19.6M |
| 4 |
UnitedHealth
UNH
|
$15.8M |
| 5 |
Revvity
RVTY
|
$14.8M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$29.2M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$20.3M |
| 3 |
Abbott
ABT
|
$20M |
| 4 |
Gilead Sciences
GILD
|
$17.5M |
| 5 |
Boston Scientific
BSX
|
$11.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Oscar Health
OSCR
$4.48B
| – | – |
-125,000
| Closed | -$1.68M |
|
102
Reviva Pharmaceuticals
RVPH
$32M
| – | – |
-514,273
| Closed | -$931K |
|
103
Sutro Biopharma
STRO
$84.3M
| – | – |
-1,727,925
| Closed | -$3.18M |
|
104
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
-196,805
| Closed | -$4.34M |
|
|
THRD
105
DELISTED
Third Harmonic Bio
THRD
| – | – |
-86,707
| Closed | -$892K |
|
|
CLYM
106
Climb Bio, Inc. Common Stock
CLYM
$151M
| – | – |
-290,491
| Closed | -$523K |
|
|
CBLL
107
CeriBell, Inc. Common Stock
CBLL
$423M
| – | – |
-32,002
| Closed | -$828K |
|
|
ITCI
108
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-243,123
| Closed | -$20.3M |
|
|
NARI
109
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-77,223
| Closed | -$3.94M |
|